First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Rating) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 55,700 shares, a growth of 19.8% from the April 30th total of 46,500 shares. Currently, 3.1% of the shares of the company are short sold. Based on an average […]
First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Rating) – Investment analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for First Wave BioPharma in a report released on Monday, May 15th. HC Wainwright analyst Y. Chen expects that the company will post earnings of ($0.53) per share for the quarter. The consensus […]
First Wave BioPharma (NASDAQ:FWBI – Get Rating) had its price target cut by HC Wainwright from $14.00 to $10.00 in a report published on Monday morning, The Fly reports. HC Wainwright also issued estimates for First Wave BioPharma’s Q2 2023 earnings at ($1.00) EPS, Q3 2023 earnings at ($0.67) EPS, Q4 2023 earnings at ($0.55) […]
First Wave BioPharma (NASDAQ:FWBI – Get Rating) had its target price lowered by HC Wainwright from $18.00 to $14.00 in a research note released on Wednesday morning, The Fly reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for First Wave BioPharma’s Q1 2023 earnings at ($1.69) EPS, […]